
CAS: 1351185-54-0

Ref: 54-BUP07366
25mg | 1.917,00 € | ||
50mg | 2.547,00 € | ||
100mg | 3.536,00 € | ||
200mg | 4.337,00 € | ||
500mg | 6.471,00 € |
Entrega estimada en Estados Unidos, el Miércoles 16 de Abril de 2025

4-[(R)-3-[4-Cyano-3-(trifluoromethyl)phenyl]-4-oxo-2-thioxo-7-oxa-1,3-diazaspiro[4.4]non-1-yl]-2-fluoro-N-methylbenzamide
Producto controladoCAS:1351185-54-0
Fórmula:
C22H16F4N4O3S
Forma y color:
Neat
Peso molecular:
492.446
Ref: TR-C778060
250mg | 9.788,00 € |
Entrega estimada en Estados Unidos, el Martes 27 de Mayo de 2025

ONC1-13B
CAS:1351185-54-0
ONC1-13B, an androgen receptor antagonist, is used potentially for the treatment of prostate cancer.
Fórmula:
C22H16F4N4O3S
Pureza:
99.45% - 99.85%
Forma y color:
Solid
Peso molecular:
492.45
Ref: TM-T28238
1mg | 279,00 € | ||
5mg | 683,00 € | ||
10mg | 938,00 € | ||
25mg | 1.415,00 € | ||
50mg | 1.882,00 € | ||
100mg | 2.612,00 € |
Entrega estimada en Estados Unidos, el Martes 3 de Junio de 2025

4-[(R)-3-[4-Cyano-3-(trifluoromethyl)phenyl]-4-oxo-2-thioxo-7-oxa-1,3-diazaspiro[4.4]non-1-yl]-2-fluoro-N-methylbenzamide
CAS:1351185-54-0
Please enquire for more information about 4-[(R)-3-[4-Cyano-3-(trifluoromethyl)phenyl]-4-oxo-2-thioxo-7-oxa-1,3-diazaspiro[4.4]non-1-yl]-2-fluoro-N-methylbenzamide including the price, delivery time and more detailed …
Fórmula:
C22H16F4N4O3S
Pureza:
Min. 95%
Peso molecular:
492.4 g/mol
Ref: 3D-BEC18554
50mg | Descatalogado | Solicitar información | |
100mg | Descatalogado | Solicitar información |